Literature DB >> 18256538

MicroRNAs in malignant progression.

Li Ma1, Robert A Weinberg.   

Abstract

A growing body of evidence suggests that certain microRNAs (miRNAs) play causal roles in tumorigenesis by regulating genes that control cellular processes such as cell cycle, apoptosis, and differentiation. Lately, work in our laboratory has revealed that a specific miRNA can cause cancer cells to invade and metastasize. Here we review recent progress made in several laboratories concerning the roles played by miRNAs in cancer pathogenesis and metastatic spread, with the focus on the pro-metastatic microRNA, miR-10b, and discuss the future directions and possibilities for clinical applications.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18256538     DOI： 10.4161/cc.7.5.5547

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


  66 in total

1.  Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.

Authors:  Byunghee Yoo; Amol Kavishwar; Alana Ross; Ping Wang; Doris P Tabassum; Kornelia Polyak; Natalia Barteneva; Victoria Petkova; Pamela Pantazopoulos; Aseda Tena; Anna Moore; Zdravka Medarova
Journal:  Cancer Res       Date:  2015-09-10       Impact factor: 12.701

2.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

Review 3.  The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms.

Authors:  Yue Teng; Xu Li
Journal:  Clin Exp Metastasis       Date:  2013-10-26       Impact factor: 5.150

4.  Epigenetic regulation of normal human mammary cell type-specific miRNAs.

Authors:  Lukas Vrba; James C Garbe; Martha R Stampfer; Bernard W Futscher
Journal:  Genome Res       Date:  2011-08-26       Impact factor: 9.043

5.  Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

Authors:  Lyndsay V Rhodes; Syreeta L Tilghman; Stephen M Boue; Shuchun Wang; Hafez Khalili; Shannon E Muir; Melyssa R Bratton; Qiang Zhang; Guangdi Wang; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

Review 6.  MicroRNA signature and regulatory functions in the endometrium during normal and disease states.

Authors:  Qun Pan; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

7.  miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.

Authors:  Elrasheid A H Kheirelseid; Nicola Miller; Kah Hoong Chang; Catherine Curran; Emer Hennessey; Margaret Sheehan; John Newell; Christophe Lemetre; Graham Balls; Michael J Kerin
Journal:  Int J Colorectal Dis       Date:  2012-08-18       Impact factor: 2.571

8.  Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.

Authors:  Claire E Repellin; Penelope M Tsimbouri; Adrian W Philbey; Joanna B Wilson
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 9.  Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.

Authors:  S Avril
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

10.  miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes.

Authors:  Weidong Chen; Zhaoqing Tang; Yihong Sun; Youyou Zhang; Xuefei Wang; Zhenbin Shen; Fenglin Liu; Xinyu Qin
Journal:  Exp Ther Med       Date:  2011-12-06       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.